Form 4 Filing for Cibus, Inc. - Gocal Gregory Francis William

This filing details a Form 4 transaction for Gregory Francis William Gocal, Chief Scientific Officer & EVP of Cibus, Inc. On April 24, 2026, Gocal acquired 57,000 shares of Class A Common Stock and 114,000 stock options. The stock acquisition was a grant with a transaction price of $0.00, resulting in a post-transaction ownership of 422,890 shares. The stock options, with an exercise price of $1.50, also had a transaction price of $0.00, leading to 114,000 options post-transaction. The options vest monthly over four years, with an expiration date of April 24, 2036.